Search companies or stocks...
RCUSArcus Biosciences, Inc.
At close · 01 Sept 2026, 08:00 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes,…
Current stock price of Arcus Biosciences, Inc. (RCUS) stock is $29.710. The stock price is +1.47% higher in the session. The intraday range can be seen from this page. Volume of Arcus Biosciences, Inc. (RCUS) stock is 1.53M.
Last updated at 01 Sept 2026, 08:00 pm.
The stock price of Arcus Biosciences, Inc. (RCUS) can change with earnings, company news, and overall market sentiment. Arcus Biosciences, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether Arcus Biosciences, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for RCUS on this page is -7.62. EPS on this page is -3.90. Compare those figures with peers and growth expectations before deciding if the current Arcus Biosciences, Inc. price is justified.
Historical performance for Arcus Biosciences, Inc. (RCUS) is shown on the price chart on this page. Review multi-period moves alongside volume to see how RCUS reacted to past earnings and market events.
Buying Arcus Biosciences, Inc. (RCUS) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
